These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3155687)
21. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). Ledbetter JA; Shu G; Gallagher M; Clark EA J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534 [TBL] [Abstract][Full Text] [Related]
22. Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor. Baeker TR; Rothstein TL J Immunol; 1985 May; 134(5):3532-8. PubMed ID: 3872333 [TBL] [Abstract][Full Text] [Related]
23. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
24. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation. Ennist DL; Elkins KL; Cheng SC; Howard M J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428 [TBL] [Abstract][Full Text] [Related]
25. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies. Klaus GG; Bijsterbosch MK; Parkhouse RM Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110 [TBL] [Abstract][Full Text] [Related]
26. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity. Defrance T; Aubry JP; Vanbervliet B; Banchereau J J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134 [TBL] [Abstract][Full Text] [Related]
27. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies. Maruyama S; Kubagawa H; Cooper MD J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101 [TBL] [Abstract][Full Text] [Related]
28. Cell cycle control of a Burkitt lymphoma cell line: responsiveness to growth signals engaging the C3D/EBV receptor. Pernegger G; Schulz TF; Hosp M; Myones BL; Petzer AL; Eigentler A; Böck G; Wick G; Dierich MP Immunology; 1988 Oct; 65(2):237-41. PubMed ID: 2461345 [TBL] [Abstract][Full Text] [Related]
29. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789 [TBL] [Abstract][Full Text] [Related]
30. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140. Pezzutto A; Dörken B; Moldenhauer G; Clark EA J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151 [TBL] [Abstract][Full Text] [Related]
31. G0 B cells activated by anti-mu acquire the ability to proliferate in response to B cell-activating factors independently from entry into G1 phase. Proust JJ; Chrest FJ; Buchholz MA; Nordin AA J Immunol; 1985 Nov; 135(5):3056-61. PubMed ID: 3900202 [TBL] [Abstract][Full Text] [Related]
32. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650 [TBL] [Abstract][Full Text] [Related]
33. The role of the transferrin receptor in human B lymphocyte activation. Neckers LM; Yenokida G; James SP J Immunol; 1984 Nov; 133(5):2437-41. PubMed ID: 6090534 [TBL] [Abstract][Full Text] [Related]
34. Separable helper factors support B cell proliferation and maturation to Ig secretion. Parker DC J Immunol; 1982 Aug; 129(2):469-74. PubMed ID: 6806371 [TBL] [Abstract][Full Text] [Related]
35. [Identification of human platelet specific functional antibody and its fragments]. Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061 [TBL] [Abstract][Full Text] [Related]
36. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. Servis C; Lambris JD J Immunol; 1989 Apr; 142(7):2207-12. PubMed ID: 2784456 [TBL] [Abstract][Full Text] [Related]
37. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4. Vazquez A; Mills S; Maizel A J Immunol; 1989 Jan; 142(1):94-9. PubMed ID: 2783328 [TBL] [Abstract][Full Text] [Related]
38. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. Udhayakumar V; Kumar L; Subbarao B J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794 [TBL] [Abstract][Full Text] [Related]
39. Monomeric IgG2 enhances Ig production and proliferation in human B cells. Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507 [TBL] [Abstract][Full Text] [Related]
40. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient. Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]